台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    50.3
  • 漲跌
    ▼1.5
  • 漲幅
    -2.90%
  • 成交量
    219
  • 產業
    上市 生技醫療類股▼0.22%
  • 128人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
和康生 (1783)籌碼相關-元大-土城永寧 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-土城永寧 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1700.00249.8049.80-2228-0.87%
2025/01/1500.00250.3049.30-2222-0.90%
2025/01/1300.00252.9052.00-2208-0.96%
2025/01/07352.3700.0052.1031761.70%
2025/01/06151.6000.0050.8011590.63%
2024/12/120.148.6000.0048.400.11260.04%
2024/12/04145.3500.0045.9511010.98%
2024/11/21545.14144.1043.7041123.55%
2024/11/1500.00141.3541.90-1112-0.89%
2024/11/08343.83144.1043.8021201.66%
2024/10/04141.9500.0041.9512550.39%
2024/08/2100.003644.6045.10-36430-8.36%
2024/07/193547.4600.0046.50353849.11%
2024/07/1800.00446.7848.00-4346-1.16%
2024/07/15445.7500.0045.2043311.21%
2024/07/121045.1000.0044.95103293.03%
2024/07/1100.00145.1545.00-1329-0.30%
2024/07/1000.00145.2045.35-1329-0.30%
2024/07/0800.00147.2547.00-1311-0.32%
2024/07/03150.6000.0050.4012840.35%
2024/07/02151.004951.1650.40-48262-18.32%
2024/07/013749.038549.4650.20-48214-22.36%
2024/06/281646.00146.1546.20151848.11%
2024/06/27745.9000.0045.8571863.76%
2024/06/2600.00547.0046.85-5179-2.78%
2024/06/24346.05345.9546.0501710.00%
2024/06/21445.801146.3746.30-7170-4.11%
2024/06/20346.00146.0545.9521681.19%
2024/06/1800.002046.0346.35-20165-12.10%
2024/06/1700.00645.3345.25-6159-3.77%
2024/06/13844.59344.5544.2551583.16%
2024/06/122044.991046.0044.80101576.37%
2024/06/11745.662045.9145.70-13157-8.24%
2024/06/07145.60245.6545.60-1155-0.64%
2024/06/0600.00945.1944.90-9154-5.82%
2024/06/05145.05445.1044.90-3153-1.96%
2024/06/04144.9000.0044.3011490.67%
2024/05/31642.50642.4942.2501400.00%
2024/05/30442.55242.7042.2021401.42%
2024/05/29142.60142.9042.6001410.00%
2024/05/28242.45342.3042.55-1141-0.71%
2024/05/27142.0000.0041.9511400.71%
2024/05/24842.27842.3842.3501360.00%
2024/05/23942.9900.0042.5091366.57%
2024/05/1700.001143.6243.60-11135-8.13%
2024/05/16343.23243.2543.1511340.74%
2024/05/14643.5000.0043.2061404.26%
2024/05/13743.40343.6343.5541422.80%
2024/05/1000.00543.0043.40-5155-3.22%
2024/05/08542.62142.6042.7041542.59%
2024/05/07742.50142.9542.4561543.89%
2024/05/03543.1000.0042.9051543.24%
2024/05/0200.000.342.8043.00-0.3154-0.20%
2024/04/15845.15145.5044.5571604.37%
2024/04/10345.7300.0046.1031631.84%
2024/04/081045.1800.0045.30101656.04%
2024/04/03646.28246.5346.0041632.45%
2024/04/02247.2500.0046.3021651.21%
2024/03/22245.001245.2145.00-10166-6.00%
2024/03/15545.25145.6545.1541672.39%
2024/03/141645.161045.5745.6561683.55%
2024/03/1311.444.8900.0044.7011.41666.84%
2024/03/080.444.5000.0044.700.41680.22%
2024/03/06445.9000.0045.5041712.34%
2024/03/05847.0200.0046.4581684.74%
2024/03/04546.6700.0046.6051672.98%
2024/03/01347.2000.0047.2031671.79%
2024/02/29347.52147.8547.6521781.12%
2024/02/26447.351247.2347.90-8179-4.45%
2024/02/23347.65347.8046.9001790.00%
2024/02/21048.1000.0047.7001880.00%
2024/02/05247.08246.6046.6001870.00%
2024/02/02147.25147.4047.3001870.00%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章